Registration Rights Agreement Dated as of June 11, 2007 among Dendreon Corporation and Merrill Lynch, Pierce, Fenner & Smith IncorporatedRegistration Rights Agreement • June 12th, 2007 • Dendreon Corp • Pharmaceutical preparations • New York
This Agreement is made pursuant to the Purchase Agreement, dated as of June 5, 2007, among the Company and the Initial Purchaser (the “Purchase Agreement”), which provides for the sale by the Company to the Initial Purchaser of $75,000,000 aggregate principal amount ($100,000,000 principal amount if the Initial Purchaser exercises its option in full) of the Company’s 4.75% Convertible Senior Subordinated Notes due 2014 (the “Securities”). In order to induce the Initial Purchaser to enter into the Purchase Agreement, the Company has agreed to provide the registration rights set forth in this Agreement. The execution of this Agreement is a condition to the closing under the Purchase Agreement.
